Effect of Non-pharmacological Therapy on Cognitive Function of Patients With Cognitive Impairment

National Institute of Medical Sciences and Nutrition, Salvador Zubiran

Status: Withdrawn

Conditions: Mild Cognitive Impairment

Treatments: Other: Non-pharmacological therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT01819623

GER-830-13/14-1

Details and patient eligibility

About

Supervised nonpharmacologic therapy improve cognitive function in patients with Mild Cognitive Impairment

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients 60 years and older with Mild Cognitive Impairment according to Petersen Criteria
• Phone number available

Exclusion criteria

• Untreated depression
• Evidence of a reversible cause of cognitive decline
• Dementia of any type and stage
• Severe sensory deficit unresolved
• Metastatic cancer
• Hemoglobin level < 8g/dL
• Chronic Obstructive Pulmonary Disease Gold stage 3 or 4
• Congestive Heart Failure decompensated, unstable angina o Functional Class IV according to New York Heart Association
• Participation in another protocol that prevents its participation in this research
• Chronic use of benzodiazepines, tricyclic antidepressants
• Patients whose place of residence can not attend the sessions

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 2 patient groups

Non-pharmacological therapy

Experimental group

Description:

This group will be supervised nonpharmacologic therapy

Treatment:

Other: Non-pharmacological therapy

Control

No Intervention group

Description:

This group will receive the standard treatment for mild cognitive impairment